Properties (106)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:Ingenuity_Systems
gptkb:Qiagen_N.V. Bioinformatics companies OmniPath |
gptkbp:awards |
Various industry awards
|
gptkbp:CEO |
Thierry_Bernard
|
gptkbp:collaborations |
With healthcare providers
With leading research institutions |
gptkbp:competitors |
gptkb:Agilent_Technologies
gptkb:Roche_Diagnostics gptkb:Thermo_Fisher_Scientific gptkb:PerkinElmer Illumina |
gptkbp:develops |
NGS_solutions
|
gptkbp:employees |
~5,000
|
gptkbp:employs |
engineers
scientists |
gptkbp:focus |
Cancer research
Clinical diagnostics Personalized medicine Sample preparation Genomic research Bioinformatics solutions Infectious disease testing |
gptkbp:focusesOn |
personalized medicine
|
gptkbp:foundedIn |
1984
1986 |
gptkbp:futurePlans |
Expansion in emerging markets
Investment in new technologies Strengthening partnerships Focus on digital health solutions Enhancement of product portfolio |
gptkbp:globalPresence |
Operations in over 25 countries
|
gptkbp:hasPart |
gptkb:GeneReader
gptkb:QIAamp_DNA_Mini_Kit QIAamp QIAseq QIAamp Blood Mini Kit QIAamp Microbiome Kit QIAamp Viral RNA Mini Kit QIAcube QIAseq Targeted RNA Panels QIAstat QIAprep QIAseq_FX_DNA_Library_Prep_Kit |
gptkbp:headquarteredIn |
gptkb:Hilden,_Germany
|
https://www.w3.org/2000/01/rdf-schema#label |
Qiagen Diagnostics
|
gptkbp:industry |
Biotechnology
|
gptkbp:isActiveIn |
clinical diagnostics
research diagnostics |
gptkbp:isIncorporatedIn |
gptkb:Netherlands
|
gptkbp:isInvolvedIn |
clinical trials
public health initiatives clinical research disease prevention therapeutic development global health solutions diagnostic development biomarker_discovery |
gptkbp:isKnownFor |
DNA extraction
RNA extraction |
gptkbp:isPartOf |
gptkb:Qiagen_N.V.
|
gptkbp:isRecognizedFor |
innovative technologies
workflow efficiency automation solutions high-quality reagents |
gptkbp:isRegulatedBy |
gptkb:FDA
EMA |
gptkbp:isSupportedBy |
technical support
customer service |
gptkbp:isUsedIn |
genetic testing
pharmacogenomics cancer diagnostics infectious disease diagnostics |
gptkbp:market |
Global market
|
gptkbp:offers |
molecular diagnostics
liquid biopsy tests |
gptkbp:operatesIn |
global market
Pharmaceutical development Molecular diagnostics Forensic testing |
gptkbp:partnerships |
Pharmaceutical companies
Various academic institutions research institutions healthcare_providers |
gptkbp:partOf |
Life sciences industry
|
gptkbp:products |
Next-generation sequencing solutions
Nucleic acid extraction kits PCR_reagents |
gptkbp:provides |
PCR tests
bioinformatics solutions |
gptkbp:researchAndDevelopment |
Significant investment
|
gptkbp:revenue |
~1.5 billion USD
|
gptkbp:serves |
clinical laboratories
|
gptkbp:specializesIn |
sample and assay technologies
|
gptkbp:subsidiary |
gptkb:Qiagen_N.V.
|
gptkbp:sustainabilityInitiatives |
Environmental responsibility programs
Community engagement programs Diversity and inclusion efforts Employee welfare programs Ethical sourcing policies |
gptkbp:technology |
Bioinformatics tools
Automation solutions Proprietary technologies |
gptkbp:website |
www.qiagen.com
|